Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Adial Pharmaceuticals Inc (ADIL)

Adial Pharmaceuticals Inc (ADIL)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 6,931
  • Shares Outstanding, K 25,854
  • Annual Sales, $ 0 K
  • Annual Income, $ -19,420 K
  • 60-Month Beta 0.57
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 1.34
Trade ADIL with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.69
  • Most Recent Earnings -0.12 on 11/14/22
  • Next Earnings Date 11/21/22
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 0.00% ( -793.87%)
  • Historical Volatility 57.03%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 976.46% on 11/07/22
  • IV Low 0.00% on 11/28/22
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 1
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 498
  • Open Int (30-Day) 2,593

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/22
See More
  • Average Estimate -0.12
  • Number of Estimates 2
  • High Estimate -0.09
  • Low Estimate -0.15
  • Prior Year -0.28
  • Growth Rate Est. (year over year) +57.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2400 +11.71%
on 11/11/22
0.3200 -16.22%
on 10/31/22
-0.0419 (-13.52%)
since 10/28/22
3-Month
0.2400 +11.71%
on 11/11/22
0.5968 -55.08%
on 08/29/22
-0.3071 (-53.39%)
since 08/26/22
52-Week
0.2400 +11.71%
on 11/11/22
3.0500 -91.21%
on 12/22/21
-2.5819 (-90.59%)
since 11/26/21

Most Recent Stories

More News
Forget Bargain Hunting: Play 5 Stocks With Rising P/E

Bet on these top-ranked stocks with rising P/E to realize outsized gains. Tap Eastside Distilling (EAST), Adial Pharmaceuticals (ADIL), The Buckle (BKE), Ruth's Hospitality Group (RUTH), Insight Enterprises...

RUTH : 17.25 (+0.82%)
BKE : 44.20 (+0.36%)
NSIT : 102.02 (-2.79%)
EAST : 0.2696 (-3.71%)
ADIL : 0.2681 (-4.25%)
Here's Why Adial Pharmaceuticals, Inc. (ADIL) Could be Great Choice for a Bottom Fisher

Adial Pharmaceuticals, Inc. (ADIL) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions...

ADIL : 0.2681 (-4.25%)
Zacks.com featured highlights include Eastside Distilling, Adial Pharmaceuticals, The Buckle, Ruth's Hospitality Group and Insight Enterprises

Eastside Distilling, Adial Pharmaceuticals, The Buckle, Ruth's Hospitality Group and Insight Enterprises are part of Zacks Screen of the Week article.

RUTH : 17.25 (+0.82%)
BKE : 44.20 (+0.36%)
NSIT : 102.02 (-2.79%)
EAST : 0.2696 (-3.71%)
ADIL : 0.2681 (-4.25%)
Forget Bargain Hunting: Play 5 Stocks With Rising P/E

Bet on these top-ranked stocks with rising P/E to realize outsized gains. Tap Eastside Distilling (EAST), Adial Pharmaceuticals (ADIL), The Buckle (BKE), Ruth's Hospitality Group (RUTH), Insight Enterprises...

RUTH : 17.25 (+0.82%)
BKE : 44.20 (+0.36%)
NSIT : 102.02 (-2.79%)
EAST : 0.2696 (-3.71%)
ADIL : 0.2681 (-4.25%)
Adial Pharmaceuticals Announces Topline Results For Onward™ Phase 3 Trial for AD04 in Patients with Alcohol Use Disorder

AD04 achieved statistically significant mean reduction in heavy drinking days among pre-specified group of heavy drinkers, compared to placebo, with an...

ADIL : 0.2681 (-4.25%)
ADILW : 0.0498 (-0.40%)
Adial Pharmaceuticals to Announce Topline Results of ONWARD™ Phase 3 Trial for AD04 in Patients With Alcohol Use Disorder

Company to host conference call on Wednesday, July 20, 2022, at 1 PM ET...

ADIL : 0.2681 (-4.25%)
ADILW : 0.0498 (-0.40%)
Twin Vee PowerCats Co.'s Board of Directors Appoints Kevin Schuyler as Newest Director

FORT PIERCE, FL / ACCESSWIRE / July 7, 2022 / Twin Vee PowerCats Co. (Nasdaq:VEEE) ("Twin Vee" or the "Company"), a designer, manufacturer, distributor, and marketer of power sport catamaran boats, today...

VEEE : 2.00 (-0.50%)
ADIL : 0.2681 (-4.25%)
Adial Pharmaceuticals Provides Letter to Shareholders From CEO William Stilley

CHARLOTTESVILLE, Va., June 28, 2022 (GLOBE NEWSWIRE) -- Adial Pharmaceuticals, Inc. (NASDAQ: ADIL; ADILW) (“Adial” or the “Company”), today issued the...

ADIL : 0.2681 (-4.25%)
ADILW : 0.0498 (-0.40%)
Adial Pharmaceuticals Announces Database Lock for the ONWARD™ Phase 3 Clinical Trial

Expects Release of Top-Line Data in July...

ADIL : 0.2681 (-4.25%)
ADILW : 0.0498 (-0.40%)
Adial Pharmaceuticals Announces Database Lock for the ONWARD™ Phase 3 Clinical Trial

Expects Release of Top-Line Data in July...

ADIL : 0.2681 (-4.25%)
ADILW : 0.0498 (-0.40%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Adial Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It focused on the development of a therapeutic agent for the treatment of alcohol use disorder. The company's lead product consists of AD04 which is in clinical stage. Adial Pharmaceuticals Inc. is based in CHARLOTTESVILLE.

See More

Key Turning Points

3rd Resistance Point 0.3224
2nd Resistance Point 0.3054
1st Resistance Point 0.2868
Last Price 0.2681
1st Support Level 0.2512
2nd Support Level 0.2342
3rd Support Level 0.2156

See More

52-Week High 3.0500
Fibonacci 61.8% 1.9766
Fibonacci 50% 1.6450
Fibonacci 38.2% 1.3134
Last Price 0.2681
52-Week Low 0.2400

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar